Selective contribution of regional adiposity, skeletal muscle, and adipokines to glucose disposal in older adults

Journal of the American Geriatrics Society

Volumn 60, Issue 4, 2012, Pages 707-712

  Ramachandran, Ramona ^a   Gravenstein, Kristofer S ^a   Metter, E Jeffrey ^a   Egan, Josephine M ^a   Ferrucci, Luigi ^a   Chia, Chee W ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Glucose disposal; Low muscle mass; Regional adiposity

Indexed keywords

ADIPONECTIN; GLUCOSE; LEPTIN;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY FAT DISTRIBUTION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE BLOOD LEVEL; HUMAN; MALE; MUSCLE MASS; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; SEX DIFFERENCE; SKELETAL MUSCLE; THIGH;

ADIPOKINES; ADIPOSE TISSUE; ADIPOSITY; AGED; AGED, 80 AND OVER; AGING; BALTIMORE; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84859860529     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03865.x     Document Type: Article

References (26)

1. Andres R. Aging and diabetes. Med Clin North America 1971;55:835-846.
2. Amati F, Dubé JJ, Coen PM et al. Physical inactivity and obesity underlie the insulin resistance of aging. Diabetes Care 2009;32:1547-1549.
3. Imbeault P, Prins JB, Stolic M et al. Aging per se does not influence glucose homeostasis. Diabetes Care 2003;26:480-484.
4. Baumgartner RN. Body composition in healthy aging. Ann NY Acad Sci 2000;904:437-448. (Pubitemid 30389235)
5. Baumgartner RN, Stauber PM, McHugh D et al. Cross-sectional age differences in body composition in persons 60+ years of age. J Gerontol A Biol Sci Med Sci 1995;50A:M307-M316.
6. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev 1993;14:72-93. (Pubitemid 23066533)
7. Kelesidis T, Kelesidis I, Chou S et al. Narrative review: The role of leptin in human physiology: Emerging clinical applications. Ann Intern Med 2010;152:93-100.
8. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13: 84-89. (Pubitemid 36740452)
9. Maffei M, Halaas J, Ravussin E et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155-1161.
10. Li S, Shin HJ, Ding EL et al. Adiponectin levels and risk of type 2 diabetes: A systematic review and meta-analysis. JAMA 2009;302:179-188.
11. DeFronzo RA, Jacot E, Jequier E et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30:1000-1007.
12. Barzilay JI, Cotsonis GA, Walston J et al. Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged > or =70 years. Diabetes Care 2009;32:736-738.
13. Park SW, Goodpaster BH, Strotmeyer ES et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes. Diabetes Care 2007;30:1507-1512.
14. Abdul-Ghani MA, Matsuda M, Balas B et al. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007;30:89-94. (Pubitemid 46052504)
15. Lohman TG RA, Martorell R. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics, 1988.
16. Expert Panel on Detection, Evaluation Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
17. Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763. (Pubitemid 28183275)
18. Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging 2009;13:708-712.
19. Taylor HL, Jacobs DR Jr, Schucker B et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1978;31:741-755. (Pubitemid 9140316)
20. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity- associated insulin resistance and dysglycemia: Findings from the National Health and Nutrition Examination Survey III. PLoS ONE 2010;5: e10805.
21. Shimokata H, Muller DC, Fleg JL et al. Age as independent determinant of glucose tolerance. Diabetes 1991;40:44-51.
22. Waters DL, Qualls CR, Dorin RI et al. Altered growth hormone, cortisol, and leptin secretion in healthy elderly persons with sarcopenia and mixed body composition phenotypes. J Gerontol A Biol Sci Med Sci 2008;63A:536-541.
23. Gill MS, Toogood A, O'Neill PA et al. Relationship between growth hormone (GH) status, serum leptin and body composition in healthy and GH deficient elderly subjects. Clin Endocrinol (Oxf) 1997;47:161-167.
24. Baratta R, Amato S, Degano C et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: Evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab 2004;89:2665-2671. (Pubitemid 38766347)
25. Koh-Banerjee P, Wang Y, Hu FB et al. Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men. Am J Epidemiol 2004;159:1150-1159. (Pubitemid 38747262)
26. Wildman RP, McGinn AP, Lin J et al. Cardiovascular disease risk of abdominal obesity vs metabolic abnormalities. Obesity 2011;19:853-860.